Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07158723 · ClinicalTrials.gov registry record · NA
Protein and Polycystic Ovary Syndrome (PCOS)
A NA study of Polycystic Ovary Syndrome (PCOS), sponsored by University of Arkansas, Fayetteville.
- Recruiting
- Registry status
- NA
- Development phase
- 60
- Enrollment target
- 2
- Study locations
NCT07158723: Recruiting NA study of Polycystic Ovary Syndrome (PCOS), sponsored by University of Arkansas, Fayetteville.
NCT07158723 is a NA study of Polycystic Ovary Syndrome (PCOS) that is actively recruiting participants, run by University of Arkansas, Fayetteville. The registered enrollment target is 60 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07158723, a NA study of Polycystic Ovary Syndrome (PCOS), is actively recruiting participants, sponsored by University of Arkansas, Fayetteville.
- RECRUITING
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
- 2
- Study locations
Study Summary
Polycystic ovary syndrome (PCOS) is a significant public health problem and is one of the most common hormonal disturbances affecting women of reproductive age. Women with PCOS are often insulin resistant, increasing their risk for cardiometabolic health problems (e.g., type 2 diabetes, heart disease, high blood pressure, sleep apnea, anxiety, depression, and stroke) especially if they are overweight. Lifestyle modifications, including dietary changes and regular physical activity, may alleviate metabolic dysfunction in women with PCOS and are often the first line of management for patients with PCOS. Several studies have identified protein as a key nutrient for regulation of energy balance, maintenance of skeletal muscle mass, and improving cardiometabolic health across the lifespan. However, the effect of increased protein intake (30% of total energy intake) on cardiometabolic health in women with PCOS has not been well-defined and mechanisms for these effects have not been identified. There is an evident need for well-designed, randomized controlled trials evaluating the efficacy of increased protein intake in women with PCOS on markers of cardiometabolic health. Preliminary data from collaborative projects with the investigators on this proposal suggest that increasing protein in the diet has the potential to improve markers of cardiometabolic health, potentially through improvements in body composition and/or changes in cortisol, energy metabolism, inflammation, and neurological regulators
Primary Outcome
Lean body mass will be measured using dual x-ray absorptiometry.
Conditions Studied
Interventions
- OTHER Higher protein dietary pattern
- OTHER Calorie restriction
Study Locations (2)
Arkansas
- Center for Human Nutrition - Fayetteville
- Center for Human Nutrition - Fayetteville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2025-08-01 |
| Est. Completion | 2027-12-03 |
| Phase | NA |
What NCT07158723 shows while recruiting
NCT07158723 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 1 condition, with Polycystic Ovary Syndrome (PCOS) appearing as the primary indexed condition, and to 2 interventions - of which Higher protein dietary pattern is the first listed.
NCT07158723 reports a single indexed study location in Arkansas.
Frequently Asked Questions
What is clinical trial NCT07158723 about?
NCT07158723 is a clinical study titled "Protein and Polycystic Ovary Syndrome (PCOS)". Polycystic ovary syndrome (PCOS) is a significant public health problem and is one of the most common hormonal disturbances affecting women of reproductive age. Women with PCOS are often insulin resistant, increasing their risk for cardiometabolic health problems (e.g., type 2 diabetes, heart diseas...
What is the current status of trial NCT07158723?
This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2025-08-01. Estimated completion is 2027-12-03.
What conditions does trial NCT07158723 study?
This clinical trial studies the following conditions: Polycystic Ovary Syndrome (PCOS).
What interventions are being tested in trial NCT07158723?
The interventions under investigation include: Higher protein dietary pattern (OTHER), Calorie restriction (OTHER).
Who is sponsoring clinical trial NCT07158723?
This trial is sponsored by University of Arkansas, Fayetteville, which has 25 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07158723 being conducted?
This trial has 2 study locations across Arkansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Polycystic Ovary Syndrome (PCOS)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07158723's enrollment target sits among peer trials
60 1164th of 2000 higher than 745 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI